安杰思净利降超两成，股东密集减持

Core Viewpoint - Anjias Medical Technology Co., Ltd. reported its first net loss since its IPO, primarily due to pressures from centralized procurement and tariff policies affecting the medical device industry [1][3]. Financial Performance - The company achieved total operating revenue of 597.21 million yuan, a decrease of 6.19% compared to the same period last year [2]. - The net profit attributable to the parent company was 222.82 million yuan, down 24.06% year-on-year [2]. - The net profit excluding non-recurring gains and losses was 191.42 million yuan, reflecting a decline of 29.81% compared to the previous year [2]. - Basic earnings per share decreased by 23.90% to 2.77 yuan [2]. - The weighted average return on net assets fell by 3.72 percentage points to 9.08% [2]. Financial Position - As of the end of the reporting period, total assets amounted to 2.67 billion yuan, an increase of 4.87% from the beginning of the period [2]. - The equity attributable to the parent company was 2.52 billion yuan, up 4.95% from the start of the period [2]. - The company's net asset per share increased by 4.27% to 31.02 yuan [2]. Industry Context - The medical device industry faced challenges due to domestic centralized procurement and overseas tariff policies, which intensified competition in the minimally invasive endoscopic treatment sector [3]. - The company maintained high levels of investment in R&D, production line updates, and domestic and international market operations, which impacted current profits [3]. Shareholder Activity - The company experienced multiple instances of shareholder reductions in 2025, with significant share sales by major shareholders [5][6]. - Notably, shareholder Tiantang Silicon Valley executed a "clearance-style" reduction, selling a total of 1.62 million shares, representing 2.0039% of the total share capital [5]. Market Performance - As of February 26, the company's stock price increased by 0.15% to 61.31 yuan per share, with a total market capitalization of 4.974 billion yuan [7].